OMNIAB, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
OMNIAB, INC. (OABI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 880.63 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-06
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 37.90K shares, a 96.11% decline year-over-year.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 842.73K shares, a 20.74% increase year-over-year.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 928.27K shares, a 484.81% increase year-over-year.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 500.13K shares, a 385.97% increase year-over-year.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 3.10M shares, a 389.13% increase from fiscal 2024.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 633.87K shares, a 4.81% increase from fiscal 2023.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 604.77K shares, a 444.11% increase from fiscal 2022.
- OMNIAB, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 111.15K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 37.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 880.63K shares 10-Q · filed 2026-08-06 | 1.81M shares derived: sum of 3 quarters · filed 2026-08-06 | 2.31M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 842.73K shares 10-Q · filed 2026-05-07 | 1.77M shares derived: sum of 2 quarters · filed 2026-05-07 | 2.27M shares derived: sum of 3 quarters · filed 2026-05-07 | 3.25M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 928.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 1.43M shares derived: sum of 2 quarters · filed 2026-03-04 | 2.40M shares derived: sum of 3 quarters · filed 2026-03-04 | 3.10M shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 500.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 1.47M shares derived: sum of 2 quarters · filed 2025-11-04 | 2.17M shares 10-Q · filed 2025-11-04 | 2.33M shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 974.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 1.67M shares 10-Q · filed 2025-08-06 | 1.83M shares derived: sum of 3 quarters · filed 2025-08-06 | 1.93M shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 697.96K shares 10-Q · filed 2025-05-08 | 856.70K shares derived: sum of 2 quarters · filed 2025-05-08 | 959.61K shares derived: sum of 3 quarters · filed 2025-05-08 | 1.19M shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 158.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | 261.64K shares derived: sum of 2 quarters · filed 2025-03-18 | 489.87K shares derived: sum of 3 quarters · filed 2025-03-18 | 633.87K shares 10-K · filed 2025-03-18 |
| 2024-09-30 | 102.91K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 331.14K shares derived: sum of 2 quarters · filed 2024-11-12 | 475.13K shares 10-Q · filed 2024-11-12 | 585.78K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 228.22K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 372.22K shares 10-Q · filed 2024-08-08 | 482.87K shares derived: sum of 3 quarters · filed 2024-08-08 | 702.94K shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 144.00K shares 10-Q · filed 2024-05-09 | 254.64K shares derived: sum of 2 quarters · filed 2024-05-09 | 474.72K shares derived: sum of 3 quarters · filed 2024-05-09 | 474.72K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 110.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 330.72K shares derived: sum of 2 quarters · filed 2024-03-25 | 330.72K shares derived: sum of 3 quarters · filed 2024-03-25 | 604.77K shares 10-K · filed 2024-03-25 |
| 2023-09-30 | 220.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 220.07K shares derived: sum of 2 quarters · filed 2023-11-09 | 494.12K shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 274.05K shares 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | 274.05K shares 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | 111.15K shares 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |